US Lower GI Series Market Research Report: By Application (Gastroenteritis, Colon Polyps, Tumor, Strictures Crohn's Disease, Ulcerative Colitis, others), By Test Types (Double-Contrast, Single-Contrast) and By End Users (Hospitals, Clinics, Laboratories) - Forecast to 2035

US Lower GI Series Market Research Report: By Application (Gastroenteritis, Colon Polyps, Tumor, Strictures Crohn's Disease, Ulcerative Colitis, others), By Test Types (Double-Contrast, Single-Contrast) and By End Users (Hospitals, Clinics, Laboratories) - Forecast to 2035.

US Lower GI Series Market Overview:

As per MRFR analysis, the US Lower GI Series Market Size was estimated at 52.18 (USD Billion) in 2023. The US Lower GI Series Market Industry is expected to grow from 56.3(USD Billion) in 2024 to 123.57 (USD Billion) by 2035. The US Lower GI Series Market CAGR (growth rate) is expected to be around 7.408% during the forecast period (2025 - 2035).

Key US Lower GI Series Market Trends Highlighted

The US Lower GI Series Market is currently witnessing significant trends driven by a growing emphasis on preventive healthcare and early diagnosis of gastrointestinal disorders. Increasing rates of conditions such as colorectal cancer have heightened awareness among both healthcare providers and patients about the importance of diagnostic procedures like lower gastrointestinal series. The US healthcare system continues to push for effective screening programs, particularly for individuals over the age of 50, which is fueling demand for these imaging procedures. Moreover, advancements in imaging technology are enhancing the accuracy and efficiency of lower GI series, making the procedure less invasive and more patient-friendly.The rise of telemedicine has also influenced how patients approach gastrointestinal health, leading to more proactive engagement in health screenings and diagnostic tests. Opportunities exist to expand outreach programs to educate the public about the benefits of early diagnostic procedures, especially in underserved populations, where awareness may be lower. In recent times, there has been a notable trend towards integrated care models that facilitate better communication between specialists and general practitioners. This shift is geared towards improving patient outcomes and ensuring timely referrals for lower GI series when needed. As the healthcare landscape evolves, providers are also exploring partnerships with technology firms to innovate how these procedures are conducted and interpreted, thus enhancing the overall patient experience.The evolving dynamics signify a robust focus on making lower GI series more accessible and effective as part of routine healthcare practices in the US.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Lower GI Series Market Drivers

Increasing Prevalence of Gastrointestinal Disorders

The US Lower GI Series Market Industry is experiencing growth due to the rising prevalence of gastrointestinal disorders such as inflammatory bowel disease, colorectal cancer, and irritable bowel syndrome. Recent data from the Centers for Disease Control and Prevention (CDC) indicates that approximately 1.6 million Americans are living with inflammatory bowel disease. This growing patient demographic is driving the demand for diagnostic imaging procedures, including Lower GI Series, as healthcare providers seek accurate methods for diagnosis.Furthermore, organizations such as the American Cancer Society advocate for early screening and detection of colorectal cancer, leading to increased utilization of Lower GI Series. Given that colorectal cancer is the second leading cause of cancer-related deaths in the United States for both men and women, the importance of these diagnostic tools cannot be understated. This trend is projected to continue over the coming years, contributing significantly to the US Lower GI Series Market growth.

Technological Advancements in Imaging Techniques

Innovations in imaging technology are a key driver for the US Lower GI Series Market Industry. Advanced imaging technologies such as high-resolution fluoroscopy and digital radiography are being adopted to enhance the accuracy and efficiency of Lower GI Series. These advancements help minimize patient exposure to radiation and improve image quality, thus supporting better diagnostic outcomes. Established organizations like the Radiological Society of North America (RSNA) promote these innovative technologies through educational seminars and training programs, further amplifying their adoption in clinical practice.The continual emergence of new technologies facilitates a transition towards more precise and timely diagnoses, which is expected to significantly boost market growth.

Increased Funding for Healthcare Infrastructure

Government initiatives to enhance healthcare infrastructure, particularly in radiology departments, are also fostering growth in the US Lower GI Series Market Industry. The Health Resources and Services Administration (HRSA) has been increasing funding for healthcare facilities, enabling hospitals and clinics to upgrade their imaging equipment and expand their diagnostics services. This investment in healthcare infrastructure allows for more widespread availability and use of Lower GI Series procedures, as patients are experiencing shorter wait times for crucial diagnostic tests.With a stronger focus on preventive healthcare and early detection of diseases, the role of Lower GI Series in the diagnostic landscape is set to expand in the coming years.

US Lower GI Series Market Segment Insights:

Lower GI Series Market Application Insights

The US Lower GI Series Market, particularly focusing on the Application segment, showcases significant growth due to the rising prevalence of various gastrointestinal disorders. This segment encompasses various conditions, including Gastroenteritis, Colon Polyps, Tumor, Strictures, Crohn's Disease, Ulcerative Colitis, and others. Gastroenteritis, often caused by infections, remains a major concern, contributing to the need for effective diagnostics through lower gastrointestinal imaging, thus driving market demand. Colon Polyps are important due to their association with colorectal cancer; early detection is crucial, leading to increased utilization of lower GI series for preventive screenings.Tumors, whether benign or malignant, require precise imaging techniques for evaluation and treatment planning, thereby emphasizing the importance of this application in oncological settings. Strictures present unique challenges as they may indicate underlying diseases; diagnostic imaging plays a vital role in assessing the severity and appropriate management. Meanwhile, Crohn's Disease and Ulcerative Colitis, which are part of inflammatory bowel diseases, are prevalent in the US population, further propelling market growth as healthcare providers seek advanced imaging solutions for optimal patient care.The US healthcare system’s emphasis on early detection and management of these conditions continues to enhance the significance of the Lower GI Series Market. Overall, with a wide array of applications targeting specific gastrointestinal disorders, this segment reflects a crucial part of diagnostic strategies that are increasingly being adopted across various healthcare settings in the US. The ongoing advancements in imaging technology and the growing awareness among patients regarding gastrointestinal health are expected to further stimulate the Application segment's growth in this dynamic market.Additionally, trends such as increasing healthcare expenditure and a shift towards outpatient diagnostic procedures align with the rising demand for lower GI series, fostering further innovation and investment within this space. The comprehensive nature of the Application segment encapsulates both diagnostic and preventive aspects, thus making it a pivotal focus for market stakeholders looking to harness opportunities in the US Lower GI Series Market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Lower GI Series Market Test Types Insights

The US Lower GI Series Market showcases a significant focus on Test Types, particularly in techniques such as Double-Contrast and Single-Contrast procedures. Each of these methods plays an essential role in the diagnostic process for gastrointestinal disorders, aiding physicians in visualizing the anatomy of the lower gastrointestinal tract more effectively. The Double-Contrast technique is particularly notable for its ability to enhance the detection of abnormalities by providing clearer images of the mucosal lining, thereby facilitating accurate diagnosis of conditions like polyps and carcinomas.In contrast, the Single-Contrast method, while simpler, is effective for quicker assessments, typically yielding satisfactory results for the evaluation of conditions such as diverticulosis. Collectively, these techniques dominate the market not only due to their efficacy but also owing to the growing prevalence of lower GI diseases in the US population, driven by factors including dietary habits and aging demographics. Furthermore, advancements in imaging technology contribute to improved outcomes, supporting the overall growth dynamics within the US Lower GI Series Market.Overall, understanding these Test Types is critical for stakeholders aiming to meet the increasing demand for effective gastrointestinal diagnostics.

Lower GI Series Market End Users Insights

The US Lower GI Series Market focuses on various end users, including hospitals, clinics, and laboratories, each playing a crucial role in the delivery of gastrointestinal imaging services. Hospitals remain prominent due to their comprehensive diagnostic capabilities, advanced technology, and emergency services, catering to a large patient population. Clinics, with their accessibility and cost-effectiveness, are increasingly preferred for routine screenings, thus contributing significantly to the growth of the market. Laboratories, essential for accurate diagnosis and analysis, support hospitals and clinics by providing vital data to aid in treatment decisions.Together, these end users reflect the growing demand for advanced imaging techniques in the US, motivated by increasing incidences of gastrointestinal disorders and the necessity for preventive measures. Market growth is driven by rising awareness, technological advancements in imaging equipment, and a shift towards outpatient care. However, challenges such as regulatory compliance and equipment costs persist but can be mitigated through strategic partnerships and innovation initiatives. Overall, the segmentation of the US Lower GI Series Market highlights the interdependent relationship between these key end users in responding to changing healthcare needs.

US Lower GI Series Market Key Players and Competitive Insights:

The US Lower GI Series Market is characterized by a robust competitive environment, driven by advancements in imaging technology and increasing demand for diagnostic procedures that ensure precise assessments of gastrointestinal health. The market landscape is shaped by various players who are continually innovating their offerings to enhance performance and patient outcomes. As healthcare providers seek to adopt more efficient and accurate diagnostic tools, the competition intensifies, resulting in a focus on providing high-quality products and services. Key players are investing in research and development to introduce improved technologies that not only meet regulatory standards but also address the changing needs of healthcare providers and patients alike. The competitive dynamics are also influenced by factors such as product differentiation, strategic partnerships, and the growth of telehealth services, all of which are reshaping how lower gastrointestinal assessments are performed across the US.Siemens Healthineers holds a prominent position in the US Lower GI Series Market, characterized by its commitment to delivering innovative imaging solutions and state-of-the-art technology. The company's portfolio features advanced imaging systems that aid in the accurate diagnosis of gastrointestinal conditions, reflecting its deep understanding of clinical needs. Siemens Healthineers benefits from a well-established presence in the healthcare landscape, bolstered by strong relationships with hospitals and imaging centers across the country. The strengths of Siemens Healthineers lie in its continuous investment in research and development, allowing it to remain at the forefront of technological advancements. This commitment not only enhances its product offerings but also ensures that healthcare providers have access to cutting-edge tools that improve patient care and streamline processes.GE Healthcare also plays a significant role in the US Lower GI Series Market, leveraging its extensive experience and technological prowess to provide comprehensive healthcare solutions. The company is known for its high-quality imaging systems, which are integral to lower gastrointestinal imaging. GE Healthcare’s strength stems from its broad product range, which includes advanced imaging technologies designed to optimize diagnostic workflows and enhance image quality. The company’s focus on innovation is exemplified by its ongoing investments in research, partnerships, and collaborations aimed at enhancing its product offerings. In terms of market presence, GE Healthcare benefits from strategic mergers and acquisitions that have expanded its portfolio and market reach, further strengthening its position in the US healthcare market. With a commitment to patient-centered solutions, GE Healthcare continues to address the evolving demands of the healthcare sector, ensuring that it remains a key player in the Lower GI Series space.

Key Companies in the US Lower GI Series Market Include:

Siemens Healthineers

GE Healthcare

Boehringer Ingelheim

Asahi Kasei Medical

Philips Healthcare

Hitachi

Johnson and Johnson

AbbVie

GSK

Fujifilm Holdings

Olympus Corporation

Hologic

C. R. Bard

Boston Scientific

Medtronic

US Lower GI Series Market Industry Developments

Recent developments in the US Lower GI Series Market have showcased significant advancements and changes among key players. Siemens Healthineers and GE Healthcare continue to innovate with enhanced imaging technologies that improve diagnostic accuracy and patient experience. Amid ongoing trends towards value-based care, companies like Philips Healthcare and Fujifilm Holdings are expanding their portfolios to include more comprehensive solutions for gastrointestinal imaging. In terms of mergers and acquisitions, Boehringer Ingelheim completed its acquisition of a niche tech firm in March 2023, focusing on digital health solutions for gastrointestinal disorders, while Johnson and Johnson announced a strategic acquisition of a diagnostic company in January 2023, solidifying its presence in the market. The valuation of companies in this sector is projected to grow due to rising healthcare expenditures and increasing demand for early disease detection among several populations, particularly older adults. Additionally, significant events such as the FDA's approval of new imaging agents in June 2022 have bolstered the market's outlook. Overall, the competitive landscape is evolving as these companies pursue innovation and expand their market reach while addressing growing consumer needs.

US Lower GI Series Market Segmentation Insights

Lower GI Series Market Application Outlook

Gastroenteritis

Colon Polyps

Tumor

Strictures Crohn's Disease

Ulcerative Colitis

others

Lower GI Series Market Test Types Outlook

Double-Contrast

Single-Contrast

Lower GI Series Market End Users Outlook

Hospitals

Clinics

Laboratories

Report Scope:

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	52.18(USD Billion)
MARKET SIZE 2024	56.3(USD Billion)
MARKET SIZE 2035	123.57(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	7.408% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Siemens Healthineers, GE Healthcare, Boehringer Ingelheim, Asahi Kasei Medical, Philips Healthcare, Hitachi, Johnson and Johnson, AbbVie, GSK, Fujifilm Holdings, Olympus Corporation, Hologic, C. R. Bard, Boston Scientific, Medtronic
SEGMENTS COVERED	Application, Test Types, End Users
KEY MARKET OPPORTUNITIES	Increasing prevalence of gastrointestinal disorders, Rising demand for non-invasive diagnostics, Technological advancements in imaging techniques, Growing awareness of preventive healthcare, Expansion of outpatient diagnostic services
KEY MARKET DYNAMICS	rising prevalence of gastrointestinal disorders, technological advancements in imaging, increasing aging population, growing awareness and diagnosis, reimbursement policy changes
COUNTRIES COVERED	US